Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.

Tänzer M, Balluff B, Distler J, Hale K, Leodolter A, Röcken C, Molnar B, Schmid R, Lofton-Day C, Schuster T, Ebert MP.

PLoS One. 2010 Feb 4;5(2):e9061. doi: 10.1371/journal.pone.0009061.

2.

[Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].

Kostin PA, Zakharzhevskaia NB, Generozov EV, Govorun VM, Chernyshov SV, Shchelygin IuA.

Vopr Onkol. 2010;56(2):162-8. Russian.

PMID:
20552891
3.

Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer.

He Q, Chen HY, Bai EQ, Luo YX, Fu RJ, He YS, Jiang J, Wang HQ.

Cancer Genet Cytogenet. 2010 Oct 1;202(1):1-10. doi: 10.1016/j.cancergencyto.2010.05.018.

PMID:
20804913
4.

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.

deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C, Habermann JK, Fleshner PR, Oubre BM, Day R, Sledziewski AZ, Lofton-Day C.

Clin Chem. 2009 Jul;55(7):1337-46. doi: 10.1373/clinchem.2008.115808. Epub 2009 Apr 30.

5.

Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.

Ebert MP, Model F, Mooney S, Hale K, Lograsso J, Tonnes-Priddy L, Hoffmann J, Csepregi A, Röcken C, Molnar B, Schulz HU, Malfertheiner P, Lofton-Day C.

Gastroenterology. 2006 Nov;131(5):1418-30. Epub 2006 Aug 18.

PMID:
17101318
6.

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay.

Grützmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F, Roblick UJ, Bruch HP, Koch R, Liebenberg V, Devos T, Song X, Day RH, Sledziewski AZ, Lofton-Day C.

PLoS One. 2008;3(11):e3759. doi: 10.1371/journal.pone.0003759. Epub 2008 Nov 19.

7.

DNA methylation biomarkers for blood-based colorectal cancer screening.

Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, Song X, Lesche R, Liebenberg V, Ebert M, Molnar B, Grützmann R, Pilarsky C, Sledziewski A.

Clin Chem. 2008 Feb;54(2):414-23. Epub 2007 Dec 18.

8.

Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.

Huang Z, Li L, Wang J.

Dig Dis Sci. 2007 Sep;52(9):2287-91. Epub 2007 Apr 5.

PMID:
17410438
9.

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, Heichman KA.

BMC Med. 2011 Dec 14;9:133. doi: 10.1186/1741-7015-9-133.

10.

SFRP2 methylation in fecal DNA--a marker for colorectal polyps.

Oberwalder M, Zitt M, Wöntner C, Fiegl H, Goebel G, Zitt M, Köhle O, Mühlmann G, Ofner D, Margreiter R, Müller HM.

Int J Colorectal Dis. 2008 Jan;23(1):15-9. Epub 2007 Jul 17.

PMID:
17639423
11.

Improved fecal DNA test for colorectal cancer screening.

Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S, Shuber A.

Clin Gastroenterol Hepatol. 2007 Jan;5(1):111-7. Epub 2006 Dec 8.

PMID:
17161655
12.

Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer.

Leung WK, To KF, Man EP, Chan MW, Bai AH, Hui AJ, Chan FK, Sung JJ.

Am J Gastroenterol. 2005 Oct;100(10):2274-9.

PMID:
16181380
13.

Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.

Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Göke B, Lamerz R, Kolligs FT.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):142-9.

PMID:
15704048
14.

Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.

Baek YH, Chang E, Kim YJ, Kim BK, Sohn JH, Park DI.

Dis Colon Rectum. 2009 Aug;52(8):1452-9; discussion 1459-63. doi: 10.1007/DCR.0b013e3181a79533.

PMID:
19617759
15.
16.
17.

Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.

Herbst A, Wallner M, Rahmig K, Stieber P, Crispin A, Lamerz R, Kolligs FT.

Eur J Gastroenterol Hepatol. 2009 May;21(5):565-9. doi: 10.1097/MEG.0b013e328318ecf2.

PMID:
19282772
18.

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ.

Gut. 2009 Oct;58(10):1375-81. doi: 10.1136/gut.2008.167817. Epub 2009 Feb 6.

PMID:
19201770
19.

Highly methylated genes in colorectal neoplasia: implications for screening.

Zou H, Harrington JJ, Shire AM, Rego RL, Wang L, Campbell ME, Oberg AL, Ahlquist DA.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2686-96.

20.

Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer.

Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, Ofner A, Crispin A, Neumann J, Lamerz R, Kolligs FT.

Am J Gastroenterol. 2011 Jun;106(6):1110-8. doi: 10.1038/ajg.2011.6. Epub 2011 Feb 15.

PMID:
21326223
Items per page

Supplemental Content

Write to the Help Desk